Research Article26th New Horizons Symposium: ARDS Update

Acute Lung Injury: Prevention May Be the Best Medicine

John M Litell, Michelle Ng Gong, Daniel Talmor and Ognjen Gajic
Respiratory Care October 2011, 56 (10) 1546-1554; DOI: https://doi.org/10.4187/respcare.01361

References

  1. 1.↵
    1. Meade MO,
    2. Jacka MJ,
    3. Cook DJ,
    4. Dodek P,
    5. Griffith L,
    6. Guyatt GH
    . Survey of interventions for the prevention and treatment of acute respiratory distress syndrome. Crit Care Med 2004;32(4):946–954.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.
    1. Matthay MA,
    2. Zimmerman GA,
    3. Esmon C,
    4. Bhattacharya J,
    5. Coller B,
    6. Doerschuk CM,
    7. et al
    . Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group Am J Respir Crit Care Med 2003;167(7):1027–1035.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Levitt JE,
    2. Matthay MA
    . The utility of clinical predictors of acute lung injury: towards prevention and earlier recognition. Expert Rev Respir Med 2010;4(6):785–797.
    OpenUrlPubMed
  4. 4.↵
    1. Bernard GR,
    2. Artigas A,
    3. Brigham KL,
    4. Carlet J,
    5. Falke K,
    6. Hudson L,
    7. et al
    . The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818–824.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Esteban A,
    2. Fernández-Segoviano P,
    3. Frutos-Vivar F,
    4. Aramburu JA,
    5. Nájera L,
    6. Ferguson ND,
    7. et al
    . Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann Intern Med 2004;141(6):440–445.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Zarbock A,
    2. Singbartl K,
    3. Ley K
    . Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 2006;116(12):3211–3219.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Navarrete-Navarro P,
    2. Rivera-Fernández R,
    3. Rincón-Ferrari MD,
    4. García-Delgado M,
    5. Muñoz A,
    6. Jiménez JM,
    7. Ortega FJ
    . Early markers of acute respiratory distress syndrome development in severe trauma patients. J Crit Care 2006;21(3):253–258.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.
    1. Laudi S,
    2. Donaubauer B,
    3. Busch T,
    4. Kerner T,
    5. Bercker S,
    6. Bail H,
    7. et al
    . Low incidence of multiple organ failure after major trauma. Injury 2007;38(9):1052–1058.
    OpenUrlCrossRefPubMed
  9. 9.
    1. Canet J,
    2. Gallart L,
    3. Gomar C,
    4. Paluzie G,
    5. Vallès J,
    6. Castillo J,
    7. et al
    ; ARISCAT Group. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology 2010;113(6):1338–1350.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Grichnik K,
    2. D'Amico T
    . Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Semin Cardiothorac Vasc Anesth 2004;8(4):317–334.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Gajic O,
    2. Lee J,
    3. Doerr CH,
    4. Berrios JC,
    5. Myers JL,
    6. Hubmayr RD
    . Ventilator-induced cell wounding and repair in the intact lung. Am J Respir Crit Care Med 2003;167(8):1057–1063.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Moloney ED,
    2. Griffiths MJD
    . Protective ventilation of patients with acute respiratory distress syndrome. Br J Anaesth 2004;92(2):261–270.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Ware LB,
    2. Matthay MA
    . The acute respiratory distress syndrome. N Engl J Med 2000;342(18):1334–1349.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Lucas R,
    2. Verin AD,
    3. Black SM,
    4. Catravas JD
    . Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol 2009;77(12):1763–1772.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Iscimen R,
    2. Cartin-Ceba R,
    3. Yilmaz M,
    4. Khan H,
    5. Hubmayr RD,
    6. Afessa B,
    7. et al
    . Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med 2008;36(5):1518–1522.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Matsushima A,
    2. Tasaki O,
    3. Shimizu K,
    4. Tomono K,
    5. Ogura H,
    6. Shimazu T,
    7. et al
    . Preemptive antibiotic treatment based on gram staining reduced the incidence of ARDS in mechanically ventilated patients. J Trauma 2008;65(2):309–315.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Kumar A,
    2. Roberts D,
    3. Wood KE,
    4. Light B,
    5. Parrillo JE,
    6. Sharma S,
    7. et al
    . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34(6):1589–1596.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Wheeler AP,
    2. Bernard GR,
    3. et al
    . Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006;354(21):2213–2224.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Murphy CV,
    2. Schramm GE,
    3. Doherty JA,
    4. Reichley RM,
    5. Gajic O,
    6. Afessa B,
    7. et al
    . The importance of fluid management in acute lung injury secondary to septic shock. Chest 2009;136(1):102–109.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342(18):1301–1308.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Yilmaz M,
    2. Keegan MT,
    3. Iscimen R,
    4. Afessa B,
    5. Buck CF,
    6. Hubmayr RD,
    7. Gajic O
    . Toward the prevention of acute lung injury: protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med 2007;35(7):1660–1666.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Kleinman S,
    2. Caulfield T,
    3. Chan P,
    4. Davenport R,
    5. McFarland J,
    6. McPhedran S,
    7. et al
    . Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004;44(12):1774–89.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Croce MA,
    2. Tolley EA,
    3. Claridge JA,
    4. Fabian TC
    . Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma 2005;59(1):19–23.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Rana R,
    2. Afessa B,
    3. Keegan MT,
    4. Whalen FX Jr.,
    5. Nuttall GA,
    6. Evenson LK,
    7. et al
    . Evidence-based red cell transfusion in the critically ill: quality improvement using computerized physician order entry. Crit Care Med 2006;34(7):1892–1897.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Khan H,
    2. Belsher J,
    3. Yilmaz M,
    4. Afessa B,
    5. Winters JL,
    6. Moore SB,
    7. et al
    . Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007;131(5):1308–1314.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Gajic O,
    2. Rana R,
    3. Winters JL,
    4. Yilmaz M,
    5. Mendez JL,
    6. Rickman OB,
    7. et al
    . Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007;176(9):886–891.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    American Association of Blood Banks. Transfusion-related acute lung injury. Bethesda, MD: November 3, 2006; Association Bulletin 06-07.
  28. 28.↵
    US Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2009. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm204763.htm. Accessed August 9, 2011.
  29. 29.↵
    1. Ferguson ND,
    2. Frutos-Vivar F,
    3. Esteban A,
    4. Gordo F,
    5. Honrubia T,
    6. Penuelas O,
    7. et al
    . Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational study. Crit Care 2007;11(5):R96.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Gajic O,
    2. Dabbagh O,
    3. Park PK,
    4. Adesanya A,
    5. Chang SY,
    6. Hou P,
    7. et al
    . Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011;183(4):462–470.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Moss M,
    2. Bucher B,
    3. Moore FA,
    4. Moore EE,
    5. Parsons PE
    . The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 1996;275(1):50–54.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Moss M,
    2. Guidot DM,
    3. Steinberg KP,
    4. Duhon GF,
    5. Treece P,
    6. Wolken R,
    7. et al
    . Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 2000;28(7):2187–2192.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Ely EW,
    2. Bernard GR
    . Transfusions in critically ill patients. N Engl J Med 1999;340(6):467–468.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Ospina-Tascon GA,
    2. Buchele GL,
    3. Vincent JL
    . Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med 2008;36(4):1311–1322.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Li G,
    2. Malinchoc M,
    3. Cartin-Ceba R,
    4. Venkata CV,
    5. Kor DJ,
    6. Peters SG,
    7. et al
    . Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med 2011;183(1):59–66.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management. Crit Care 2008;12(1):R30.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Gajic O,
    2. Afessa B,
    3. Thompson BT,
    4. Frutos-Vivar F,
    5. Malinchoc M,
    6. Rubenfeld GD,
    7. et al
    . Prediction of death and prolonged mechanical ventilation in acute lung injury. Crit Care 2007;11(3):R53.
    OpenUrlPubMed
  38. 38.↵
    1. Trillo-Alvarez C,
    2. Cartin-Ceba R,
    3. Kor DJ,
    4. Kojicic M,
    5. Kashyap R,
    6. Thakur S,
    7. et al
    . Acute lung injury prediction score: derivation and validation in a population based sample. Eur Respir J 2011;37(3):604–609.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Squadrone V,
    2. Massaia M,
    3. Bruno B,
    4. Marmont F,
    5. Falda M,
    6. Bagna C,
    7. et al
    . Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med 2010;36(10):1666–1674.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    1. Agarwal R,
    2. Aggarwal AN,
    3. Gupta D
    . Role of noninvasive ventilation in acute lung injury/acute respiratory distress syndrome: a proportion meta-analysis. Respir Care 2010;55(12):1653–1660.
    OpenUrlPubMed
  41. 41.↵
    1. Beck-Schimmer B,
    2. Bonvini JM
    . Bronchoaspiration: incidence, consequences and management. Eur J Anaesthesiol 2011;28(2):78–84.
    OpenUrlPubMed
  42. 42.↵
    1. Erlich JM,
    2. Talmor DS,
    3. Cartin-Ceba R,
    4. Gajic O,
    5. Kor DJ
    . Pre-hospitalization anti-platelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest 2011;139(2):289–95.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Jepsen S,
    2. Herlevsen P,
    3. Knudsen P
    . Antioxidant treatment with N-acetylcyesteine during adult respiratory distress syndrome: a prospective randomized placebo controlled study. Crit Care Med 1992;20(7):819–923.
    OpenUrl
  44. 44.↵
    1. Miller AC,
    2. Rivero A,
    3. Ziad S,
    4. Elamin EM,
    5. Smith DJ
    . Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury. J Burn Care Res 2009;30(2):249–256.
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    1. Bhatia M,
    2. Moochhala S
    . Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004;202(2):145–156.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    1. Davreux CJ,
    2. Soric I,
    3. Nathens AB,
    4. Watson RW,
    5. McGilvray ID,
    6. Suntres ZE,
    7. et al
    . N-acetyl cysteine attenuates acute lung injury in the rat. Shock 1997;8(6):432–438.
    OpenUrlPubMedWeb of Science
  47. 47.↵
    1. Perkins GD,
    2. McAuley DF,
    3. Thickett DR,
    4. Gao F
    . The Beta Agonist Lung Injury Trial (BALTI) a randomised placebo controlled clinical trial. Am J Respir Crit Care Med 2005;173(3):281–287.
    OpenUrlPubMed
  48. 48.↵
    1. Bone RC,
    2. Fisher CJ Jr.,
    3. Clemmer TP,
    4. Slotman GJ,
    5. Metz CA
    . Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987;92(6):1032–6.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    1. Reade MC,
    2. Milbrandt EB
    . Is there evidence to support a phase II trial of inhaled corticosteroids in the treatment of incipient and persistent ARDS? Crit Care Resusc 2007;9(3):276–285.
    OpenUrlPubMed
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords